jama semaglutide and #tirzepatide have improved #obesity treatment but necessitate careful dosing and lifestyle adjustments to manage gastrointestinal side effects and ensure sustainable weight loss. https://ja.ma/466v73R JAMA Cardiology Letter Highlights Limitations

We report 2 patients with chronic kidney disease due to diabetic kidney disease who experienced rapid worsening of kidney function and increased proteinuria after being prescribed the GLP-1 receptor agonist semaglutide

Day 4 Breakfast (331 calories) A.M

Disrupted sleep or high cortisol increases constipation

Well be looking at a few things as we head into 2026 here: Will the rise in warning letters continue, or was FY 2025 an outlier reflecting catch-up activity

Were going to unpack how poor sleep can quietly sabotage progress in even the most committed medical weight loss journey

This pricing structure allows you to explore whether semaglutide produces personal benefits without escalating costs as therapeutic doses increase